A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
for Multiple Sclerosis (MS) Primary Progressive
11 locations incl. Pheonix
Sponsor: Zenas BioPharma (USA), LLC
Sex: All·Age: 18 - 60
Code: NCT07067463·Phase 3·Recruiting